Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01597635
First received: January 26, 2012
Last updated: October 20, 2016
Last verified: October 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 19, 2015